Bicara Therapeutics, Inc. (BCAX)
18.76
+0.60
(+3.30%)
USD |
NASDAQ |
Dec 04, 16:00
18.78
+0.02
(+0.11%)
After-Hours: 20:00
Bicara Therapeutics Total Liabilities (Quarterly): 21.91M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Oncotelic Therapeutics, Inc. | 20.08M |
| Dogwood Therapeutics, Inc. | 14.61M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 424.69M |
| Shareholders Equity (Quarterly) | 402.78M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 14.14 |
| Net Debt Paydown Yield | -0.03% |